THE NOVEL CANNABINOID CB1 ANTAGONIST AM6545 SUPPRESSES FOOD INTAKE AND FOOD-REINFORCED BEHAVIOR

Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors, and may be useful clinically as appetite suppressants. However, there may also be undesirable side effects (e.g., nausea, malaise, anxiety, depression) that are produced by the current generation of CB1 inverse...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Randall, P.A., Vemuri, V.K., Segovia, K.N., Torres, E. Ferreris, Hosmer, S., Nunes, E.J., Santerre, J.L., Makriyannis, A., Salamone, J.D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522179/
https://ncbi.nlm.nih.gov/pubmed/20713079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2010.07.021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares